Free tool
FAERS Monitor: Ambien
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019908 or its brand name (Ambien, Zolpidem Tartrate). Reports on generic versions are filed under their own applications.
Reports
82,817
Serious
52,480
63% of reports
Hospitalization
25,874
Death reported
7,310
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea5,914
- fatigue5,777
- drug ineffective5,689
- insomnia4,680
- pain4,603
- headache4,367
- diarrhoea4,059
- anxiety3,815
- dizziness3,689
- dyspnoea3,615
- fall3,517
- depression3,309
- vomiting3,297
- asthenia3,098
- arthralgia2,582
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,922 |
| 2005 | 2,499 |
| 2006 | 3,251 |
| 2007 | 3,022 |
| 2008 | 2,367 |
| 2009 | 3,104 |
| 2010 | 3,728 |
| 2011 | 3,508 |
| 2012 | 4,600 |
| 2013 | 3,772 |
| 2014 | 3,793 |
| 2015 | 5,836 |
| 2016 | 6,337 |
| 2017 | 4,788 |
| 2018 | 5,961 |
| 2019 | 4,567 |
| 2020 | 3,762 |
| 2021 | 2,842 |
| 2022 | 2,909 |
| 2023 | 2,650 |
| 2024 | 2,755 |
| 2025 | 2,793 |
| 2026 | 2,046 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,971,342 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| insomniaSignal | 4,680 | 4.5 | 4.4 | 12,781 |
| depressionSignal | 3,309 | 3.7 | 3.6 | 6,594 |
| anxietySignal | 3,815 | 3.4 | 3.3 | 6,591 |
| fallSignal | 3,517 | 2.7 | 2.6 | 3,788 |
| astheniaSignal | 3,098 | 2.1 | 2.0 | 1,805 |
| pain | 4,603 | 1.9 | 1.9 | 2,039 |
| nausea | 5,914 | 1.9 | 1.9 | 2,619 |
| fatigue | 5,777 | 1.9 | 1.8 | 2,499 |
| dizziness | 3,689 | 1.9 | 1.8 | 1,557 |
| vomiting | 3,297 | 1.8 | 1.7 | 1,159 |
| headache | 4,367 | 1.8 | 1.7 | 1,510 |
| dyspnoea | 3,615 | 1.6 | 1.6 | 889 |
| diarrhoea | 4,059 | 1.6 | 1.6 | 938 |
| arthralgia | 2,582 | 1.6 | 1.5 | 558 |
| drug ineffective | 5,689 | 1.1 | 1.1 | 51 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.